Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)

• Główni autorzy: Jingxin Fu (Autor), Kunfeng Zhang (Autor), Likang Lu (Autor), Manzhen Li (Autor), Meihua Han (Autor), Yifei Guo (Autor), Xiangtao Wang (Autor)
• Format: Książka
• Wydane: MDPI AG, 2022-07-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Cannabidiol (CBD), a nonpsychoactive major component derived from <i>Cannabis sativa</i>, widely used in neurodegenerative diseases, has now been proven to have growth inhibitory effects on many tumor cell lines, including breast tumors. Meanwhile CBD can effectively alleviate cancer-ass...